Boston and Medtronic to fight stent verdict and damages
This article was originally published in Clinica
Boston Scientific and Medtronic have each been ordered to pay large damages to Johnson & Johnson after the companies were found to have infringed J&J's stent patents. In separate pieces of litigation, Boston was told to pay $324.4 million, while Medtronic's figure is $271.1 million. The two companies are likely to appeal.